title: [EHF-therapy of herpetic keratouveitis].
abstract: A device BIK for active suppression of infection has been used against Herpes virus infection type 1 and 2 in 72 patients with keratouveitis. The immunological and genotypic monitoring show that patients with herpetic keratouveitis after BIK treatment have lower titers of antiherpetic antibodies, normal cellular and humoral immunity, weaker viremia and reduced quantity of viral material in corneal tissue. This positive effect persisted for 8-12 months. Thus, BIK device provides a definite, prolonged and stable therapeutic effect in patients with herpetic keratouveitis.
authors.forename: M Iu
authors.initials: MIu
authors.lastname: Gerasimenko
authors.forename: A A
authors.initials: AA
authors.lastname: Riabtseva
authors.forename: N L
authors.initials: NL
authors.lastname: Goncharenko
authors.forename: S V
authors.initials: SV
authors.lastname: Suchkov
authors.forename: E V
authors.initials: EV
authors.lastname: Kuvshinov
authors.forename: E V
authors.initials: EV
authors.lastname: Filatova
mesh_terms: D000328:Adult; D055590:Electromagnetic Phenomena / Q000295:instrumentation / Q000379:methods*; D018259:Herpesvirus 1, Human / Q000528:radiation effects*; D018258:Herpesvirus 2, Human / Q000528:radiation effects*; D006801:Humans; D016849:Keratitis, Herpetic / Q000628:therapy* / Q000821:virology; D008875:Middle Aged; D014605:Uveitis / Q000628:therapy* / Q000821:virology